Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Aquacel
2. Aquaplast
3. Carboxymethyl Cellulose
4. Carboxymethylcellulose
5. Carboxymethylcellulose Sodium
6. Carboxymethylcellulose, Sodium
7. Carmellose Sodium
8. Cellolax
9. Cellulose, Carboxymethyl
10. Cethylose
11. Croscarmellose Sodium
12. Polycell
13. Ruspol
14. Sodium Carboxymethylcellulose
15. Sodium, Carboxymethylcellulose
16. Sodium, Carmellose
17. Sodium, Croscarmellose
1. Carboxymethylcellulose
2. Carboxymethyl Cellulose
3. 9000-11-7
4. Acetic Acid;2,3,4,5,6-pentahydroxyhexanal
5. Cellulose, Carboxymethyl Ether
6. Cellulose Cm
7. Colloresine
8. Carmellose
9. Almelose
10. Apergel
11. Carbose
12. Duodcel
13. Thylose
14. Apeyel
15. Carboxymethylcellulose Cellulose Carboxymethyl Ether
16. Cm-cellulose
17. Glycocel Ta
18. Kmts
19. 7h (carbohydrate)
20. Cellulose Gum 7h
21. Celluloseglycolic Acid
22. Carboximethylcellulosum
23. Carboxymethylcellulosum
24. Croscarmellosum [latin]
25. Cellulose Carboxymethylate
26. Carmellosum [inn-latin]
27. Carmelosa [inn-spanish]
28. Cmc-4lf
29. Cellulose, (carboxymethyl)
30. Carboxymethyl Cellulose Ether
31. Carmellosum
32. Croscarmellosum
33. Croscarmellosum [inn-latin]
34. Croscarmelosa
35. Croscarmelosa [inn-spanish]
36. Glycolic Acid Cellulose Ether
37. Carmelosa
38. Fema No. 2239
39. Carboxymethylated Cellulose Pulp
40. Carmellose [inn]
41. Cellulose, Ether With Glycolic Acid
42. Intrasite Gel (tn)
43. .carboxymethylcellulose
44. Acetic Acid, Hydroxy-, Cellulose Ether
45. Croscarmellose (inn)
46. Unii-05jzi7b19x
47. 7h
48. Schembl177710
49. Carmellose (jp17/nf/inn)
50. 05jzi7b19x
51. Ft-0623543
52. D07622
53. Q411030
54. 191616-54-3
55. 196886-89-2
Molecular Weight | 240.21 g/mol |
---|---|
Molecular Formula | C8H16O8 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 240.08451746 g/mol |
Monoisotopic Mass | 240.08451746 g/mol |
Topological Polar Surface Area | 156 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 169 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 4 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Indicated for the symptomatic relief of burning, irritation and discomfort of the eyes due to dryness or exposure to wind or sun.
In a randomized clinical study of patients with mild or moderate forms of eye dryness, ophthalmic treatment with sodium carboxymethylcellulose resulted in a diminished frequency of symptoms compared to the placebo group. Carboxymethylcellulose interacts with human corneal epithelial cells to facilitate corneal epithelial wound healing and attenuate eye irritation in a dose-dependent manner. It exhibits protective actions on the ocular surface in various applications; it mediates cytoprotective effects on the ocular surface when applied prior to contact lenses and reduces the incidence of epithelial defects during LASIK.
Laxatives
Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION. (See all compounds classified as Laxatives.)
Absorption
No pharmacokinetic data available.
Route of Elimination
No pharmacokinetic data available.
Volume of Distribution
No pharmacokinetic data available.
Clearance
No pharmacokinetic data available.
No pharmacokinetic data available.
No pharmacokinetic data available.
Carboxymethylcellulose binds to the surface of corneal epithelial cells via its glucopyranose subunits binding to glucose receptors GLUT-1. The residence time of carboxymethylcellulose bound to corneal cells is approximately 2 hours as indicated by a short-term binding assay. Binding of carboxymethylcellulose to the matrix proteins stimulated corneal epithelial cell attachment, migration, and re-epithelialization of corneal wounds.
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
14
PharmaCompass offers a list of Carboxymethyl Cellulose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carboxymethyl Cellulose manufacturer or Carboxymethyl Cellulose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carboxymethyl Cellulose manufacturer or Carboxymethyl Cellulose supplier.
PharmaCompass also assists you with knowing the Carboxymethyl Cellulose API Price utilized in the formulation of products. Carboxymethyl Cellulose API Price is not always fixed or binding as the Carboxymethyl Cellulose Price is obtained through a variety of data sources. The Carboxymethyl Cellulose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Croscarmellose (INN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Croscarmellose (INN), including repackagers and relabelers. The FDA regulates Croscarmellose (INN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Croscarmellose (INN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Croscarmellose (INN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Croscarmellose (INN) supplier is an individual or a company that provides Croscarmellose (INN) active pharmaceutical ingredient (API) or Croscarmellose (INN) finished formulations upon request. The Croscarmellose (INN) suppliers may include Croscarmellose (INN) API manufacturers, exporters, distributors and traders.
click here to find a list of Croscarmellose (INN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Croscarmellose (INN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Croscarmellose (INN) active pharmaceutical ingredient (API) in detail. Different forms of Croscarmellose (INN) DMFs exist exist since differing nations have different regulations, such as Croscarmellose (INN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Croscarmellose (INN) DMF submitted to regulatory agencies in the US is known as a USDMF. Croscarmellose (INN) USDMF includes data on Croscarmellose (INN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Croscarmellose (INN) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Croscarmellose (INN) suppliers with USDMF on PharmaCompass.
Croscarmellose (INN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Croscarmellose (INN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Croscarmellose (INN) GMP manufacturer or Croscarmellose (INN) GMP API supplier for your needs.
A Croscarmellose (INN) CoA (Certificate of Analysis) is a formal document that attests to Croscarmellose (INN)'s compliance with Croscarmellose (INN) specifications and serves as a tool for batch-level quality control.
Croscarmellose (INN) CoA mostly includes findings from lab analyses of a specific batch. For each Croscarmellose (INN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Croscarmellose (INN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Croscarmellose (INN) EP), Croscarmellose (INN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Croscarmellose (INN) USP).